1887

Abstract

Clustered regularly interspaced short palindromic repeat (CRISPR)-Cas systems are bacterial defences that target bacteriophages and mobile genetic elements. How these defences evolve in novel host environments remains largely unknown. We studied the evolution of the CRISPR-Cas system in (also named ), a bacterial pathogen of poultry that jumped into a passerine host ~30 years ago. Over the decade following the host shift, all isolates displaying a functional CRISPR-Cas system were found not only to harbour completely new sets of spacers, but the DNA protospacer adjacent motif recognized by the main effector Cas9 (MgCas9) was also different. These changes in CRISPR-Cas diversity and specificity are consistent with a change in the community of phages and mobile elements infecting as it colonized the novel host. In the years following the host shift, we also detected a gradual rise in isolates displaying non-functional MgCas9. After 12 years, all circulating isolates harboured inactive forms only. This loss of CRISPR-Cas function comes at a time when the passerine host is known to have evolved widespread resistance, which in turn drove the evolution of increasing virulence through antagonistic coevolution. Such striking concordance in the rise of inactivated forms of CRISPR-Cas and the evolution of host resistance suggests that the inactivation of the CRISPR-Cas system was necessary for enabling adaptive bacterial responses to host-driven selection. We highlight the need to consider both host and pathogen selection pressures on bacteria for understanding the evolution of CRISPR-Cas systems and the key factors driving the emergence of a pathogenic bacterium in a novel host.

Funding
This study was supported by the:
  • Royal Society (Award RG150088)
    • Principle Award Recipient: CamilleBonneaud
  • UK Natural Environment Research Council standard (Award NE/M00256X)
    • Principle Award Recipient: CamilleBonneaud
  • This is an open-access article distributed under the terms of the Creative Commons Attribution License. This article was made open access via a Publish and Read agreement between the Microbiology Society and the corresponding author’s institution.
Loading

Article metrics loading...

/content/journal/mgen/10.1099/mgen.0.001320
2024-11-18
2024-12-09
Loading full text...

Full text loading...

/deliver/fulltext/mgen/10/11/mgen001320.html?itemId=/content/journal/mgen/10.1099/mgen.0.001320&mimeType=html&fmt=ahah

References

  1. Ipoutcha T, Tsarmpopoulos I, Géraldine G, Vincent B, Paul D et al. Evolution of the CRISPR-cas9 defence system in mycoplasma gallisepticum following colonization of a novel bird host. Figshare 2024 https://doi.org/10.6084/m9.figshare.27165426.v1
    [Google Scholar]
  2. Barrangou R, Fremaux C, Deveau H, Richards M, Boyaval P et al. CRISPR provides acquired resistance against viruses in prokaryotes. Science 2007; 315:1709–1712 [View Article] [PubMed]
    [Google Scholar]
  3. Zaayman M, Wheatley RM. Fitness costs of CRISPR-Cas systems in bacteria. Microbiology 2022; 168: [View Article] [PubMed]
    [Google Scholar]
  4. Koonin EV. CRISPR: a new principle of genome engineering linked to conceptual shifts in evolutionary biology. Biol Philos 2019; 34:9 [View Article] [PubMed]
    [Google Scholar]
  5. Makarova KS, Wolf YI, Iranzo J, Shmakov SA, Alkhnbashi OS et al. Evolutionary classification of CRISPR-Cas systems: a burst of class 2 and derived variants. Nat Rev Microbiol 2020; 18:67–83 [View Article] [PubMed]
    [Google Scholar]
  6. Dimitriu T, Szczelkun MD, Westra ER. Evolutionary ecology and interplay of prokaryotic innate and adaptive immune systems. Curr Biol 2020; 30:R1189–R1202 [View Article] [PubMed]
    [Google Scholar]
  7. Bonneaud C, Tardy L, Giraudeau M, Hill GE, McGraw KJ et al. Evolution of both host resistance and tolerance to an emerging bacterial pathogen. Evol Lett 2019; 3:544–554 [View Article]
    [Google Scholar]
  8. Stallknecht DE, Luttrell MP, Fischer JR, Kleven SH. Potential for transmission of the finch strain of Mycoplasma gallisepticum between house finches and chickens. Avian Dis 1998; 42:352 [View Article]
    [Google Scholar]
  9. Ley DH, Berkhoff JE, McLaren JM. Mycoplasma gallisepticum isolated from house finches (Carpodacus mexicanus) with conjunctivitis. Avian Dis 1996; 40:480–483 [PubMed]
    [Google Scholar]
  10. Delaney NF, Balenger S, Bonneaud C, Marx CJ, Hill GE et al. Ultrafast evolution and loss of CRISPRs following a host shift in a novel wildlife pathogen, Mycoplasma gallisepticum. PLoS Genet 2012; 8:e1002511 [View Article] [PubMed]
    [Google Scholar]
  11. Tulman ER, Liao X, Szczepanek SM, Ley DH, Kutish GF et al. Extensive variation in surface lipoprotein gene content and genomic changes associated with virulence during evolution of a novel North American house finch epizootic strain of Mycoplasma gallisepticum. Microbiology 2012; 158:2073–2088 [View Article] [PubMed]
    [Google Scholar]
  12. May M, Balish MF, Blanchard A. The order Mycoplasmatales. In The Prokaryotes Springer Berlin Heidelberg; 2014 pp 515–550 [View Article]
    [Google Scholar]
  13. Citti C, Dordet-Frisoni E, Nouvel LX, Kuo CH, Baranowski E. Horizontal gene transfers in Mycoplasmas (Mollicutes). Curr Issues Mol Biol 2018; 29:3–22 [View Article] [PubMed]
    [Google Scholar]
  14. Sirand-Pugnet P, Citti C, Barré A, Blanchard A. Evolution of mollicutes: down a bumpy road with twists and turns. Res Microbiol 2007; 158:754–766 [View Article] [PubMed]
    [Google Scholar]
  15. Oliveira PH, Touchon M, Rocha EPC. The interplay of restriction-modification systems with mobile genetic elements and their prokaryotic hosts. Nucleic Acids Res 2014; 42:10618–10631 [View Article] [PubMed]
    [Google Scholar]
  16. Ipoutcha T, Tsarmpopoulos I, Talenton V, Gaspin C, Moisan A et al. Multiple origins and specific evolution of CRISPR/Cas9 systems in minimal bacteria (Mollicutes). Front Microbiol 2019; 10:2701 [View Article] [PubMed]
    [Google Scholar]
  17. Dhondt AA, Tessaglia DL, Slothower RL. Epidemic from conjunctivitis america in house finches. J Wildl Dis 1998; 34:265–280 [View Article]
    [Google Scholar]
  18. Heler R, Samai P, Modell JW, Weiner C, Goldberg GW et al. Cas9 specifies functional viral targets during CRISPR-Cas adaptation. Nature 2015; 519:199–202 [View Article] [PubMed]
    [Google Scholar]
  19. Wei Y, Terns RM, Terns MP. Cas9 function and host genome sampling in type II-A CRISPR–cas adaptation. Genes Dev 2015; 29:356–361 [View Article]
    [Google Scholar]
  20. Bonneaud C, Giraudeau M, Tardy L, Staley M, Hill GE et al. Rapid antagonistic coevolution in an emerging pathogen and its vertebrate host. Curr Biol 2018; 28:2978–2983 [View Article] [PubMed]
    [Google Scholar]
  21. Tardy L, Giraudeau M, Hill GE, McGraw KJ, Bonneaud C. Contrasting evolution of virulence and replication rate in an emerging bacterial pathogen. Proc Natl Acad Sci U S A 2019; 116:16927–16932 [View Article] [PubMed]
    [Google Scholar]
  22. Kumar S, Stecher G, Li M, Knyaz C, Tamura K. MEGA X: molecular evolutionary genetics analysis across computing platforms. Mol Biol Evol 2018; 35:1547–1549 [View Article]
    [Google Scholar]
  23. Darling ACE, Mau B, Blattner FR, Perna NT. Mauve: multiple alignment of conserved genomic sequence with rearrangements. Genome Res 2004; 14:1394–1403 [View Article] [PubMed]
    [Google Scholar]
  24. Li W, Godzik A. Cd-hit: a fast program for clustering and comparing large sets of protein or nucleotide sequences. Bioinformatics 2006; 22:1658–1659 [View Article] [PubMed]
    [Google Scholar]
  25. Arndt D, Grant JR, Marcu A, Sajed T, Pon A et al. PHASTER: a better, faster version of the PHAST phage search tool. Nucleic Acids Res 2016; 44:W16–21 [View Article] [PubMed]
    [Google Scholar]
  26. Chen I-MA, Chu K, Palaniappan K, Pillay M, Ratner A et al. IMG/M v.5.0: an integrated data management and comparative analysis system for microbial genomes and microbiomes. Nucleic Acids Res 2019; 47:D666–D677 [View Article] [PubMed]
    [Google Scholar]
  27. Jinek M, Chylinski K, Fonfara I, Hauer M, Doudna JA et al. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 2012; 337:816–821 [View Article] [PubMed]
    [Google Scholar]
  28. Freundt EA. Culture media for classic mycoplasmas. In Methods in Mycoplasmology 1983 [View Article]
    [Google Scholar]
  29. Ipoutcha T, Gourgues G, Lartigue C, Blanchard A, Sirand-Pugnet P. Genome engineering in Mycoplasma gallisepticum using exogenous recombination systems. ACS Synth Biol 2022; 11:1060–1067 [View Article] [PubMed]
    [Google Scholar]
  30. Gasiunas G, Young JK, Karvelis T, Kazlauskas D, Urbaitis T et al. A catalogue of biochemically diverse CRISPR-Cas9 orthologs. Nat Commun 2020; 11:5512 [View Article] [PubMed]
    [Google Scholar]
  31. Karvelis T, Young JK, Siksnys V. A Pipeline for Characterization of Novel Cas9 Orthologs, 1st edn Elsevier Inc; 2019 [View Article]
    [Google Scholar]
  32. Leigh SA, Evans JD, Branton SL. Complete genome sequences of two Mycoplasma gallisepticum F-strain variants. Microbiol Resour Announc 2019; 8:e00485-19 [View Article] [PubMed]
    [Google Scholar]
  33. Leigh SA, Evans JD, Branton SL. Complete genome sequences of two vaccine strains and one field isolate of Mycoplasma gallisepticum. Microbiol Resour Announc 2019; 8:e01237-19 [View Article] [PubMed]
    [Google Scholar]
  34. Papazisi L, Gorton TS, Kutish G, Markham PF, Browning GF et al. The complete genome sequence of the avian pathogen Mycoplasma gallisepticum strain R(low). Microbiology 2003; 149:2307–2316 [View Article] [PubMed]
    [Google Scholar]
  35. Song Y, Kim T, La T-M, Lee H-J, Lee Y et al. Complete genome sequence of Mycoplasma gallisepticum strain KUVMG001, an isolate from South Korea. Microbiol Resour Announc 2021; 10:e00331-21 [View Article] [PubMed]
    [Google Scholar]
  36. Szczepanek SM, Tulman ER, Gorton TS, Liao X, Lu Z et al. Comparative genomic analyses of attenuated strains of Mycoplasma gallisepticum. Infect Immun 2010; 78:1760–1771 [View Article] [PubMed]
    [Google Scholar]
  37. Hill V, Akarsu H, Barbarroja RS, Cippà VL, Kuhnert P et al. Minimalistic mycoplasmas harbor different functional toxin-antitoxin systems. PLoS Genet 2021; 17:e1009365 [View Article] [PubMed]
    [Google Scholar]
  38. Vink JNA, Baijens JHL, Brouns SJJ. Comprehensive PAM prediction for CRISPR-Cas systems reveals evidence for spacer sharing, preferred strand targeting and conserved links with CRISPR repeats. bioRxiv 2021 [View Article]
    [Google Scholar]
  39. Calcutt MJ, Lewis MS, Wise KS. Molecular genetic analysis of ICEF, an integrative conjugal element that is present as a repetitive sequence in the chromosome of Mycoplasma fermentans PG18. J Bacteriol 2002; 184:6929–6941 [View Article] [PubMed]
    [Google Scholar]
  40. Dordet Frisoni E, Marenda MS, Sagné E, Nouvel LX, Guérillot R et al. ICEA of Mycoplasma agalactiae: a new family of self-transmissible integrative elements that confers conjugative properties to the recipient strain. Mol Microbiol 2013; 89:1226–1239 [View Article] [PubMed]
    [Google Scholar]
  41. Meygret A, Peuchant O, Dordet-Frisoni E, Sirand-Pugnet P, Citti C et al. High prevalence of integrative and conjugative elements encoding transcription activator-like effector repeats in Mycoplasma hominis. Front Microbiol 2019; 10:2385 [View Article] [PubMed]
    [Google Scholar]
  42. Westra ER, Levin BR. It is unclear how important CRISPR-cas systems are for protecting natural populations of bacteria against infections by mobile genetic elements. Proc Natl Acad Sci U S A 2020; 117:27777–27785 [View Article] [PubMed]
    [Google Scholar]
  43. Hall JPJ, Wright RCT, Harrison E, Muddiman KJ, Wood AJ et al. Plasmid fitness costs are caused by specific genetic conflicts enabling resolution by compensatory mutation. PLoS Biol 2021; 19:e3001225 [View Article] [PubMed]
    [Google Scholar]
  44. Vale PF, Lafforgue G, Gatchitch F, Gardan R, Moineau S et al. Costs of CRISPR-Cas-mediated resistance in Streptococcus thermophilus. Proc Biol Sci 2015; 282:20151270 [View Article] [PubMed]
    [Google Scholar]
  45. Broniewski JM, Meaden S, Paterson S, Buckling A, Westra ER. The effect of phage genetic diversity on bacterial resistance evolution. ISME J 2020; 14:828–836 [View Article] [PubMed]
    [Google Scholar]
  46. Stern A, Keren L, Wurtzel O, Amitai G, Sorek R. Self-targeting by CRISPR: gene regulation or autoimmunity?. Trends Genet 2010; 26:335–340 [View Article] [PubMed]
    [Google Scholar]
  47. Watson BNJ, Capria L, Alseth EO, Pons BJ, Biswas A et al. CRISPR-Cas in Pseudomonas aeruginosa provides transient population-level immunity against high phage exposures. ISME J 2024; 18:wrad039 [View Article] [PubMed]
    [Google Scholar]
  48. Wimmer F, Beisel CL. CRISPR-cas systems and the paradox of self-targeting spacers. Front Microbiol 2019; 10:3078 [View Article] [PubMed]
    [Google Scholar]
  49. Alduhaidhawi AHM, AlHuchaimi SN, Al-Mayah TA, Al-Ouqaili MTS, Alkafaas SS et al. Prevalence of CRISPR-cas systems and their possible association with antibiotic resistance in Enterococcus faecalis and Enterococcus faecium collected from hospital wastewater. Infect Drug Resist 2022; 15:1143–1154 [View Article] [PubMed]
    [Google Scholar]
  50. Bikard D, Hatoum-Aslan A, Mucida D, Marraffini LA. CRISPR interference can prevent natural transformation and virulence acquisition during in vivo bacterial infection. Cell Host Microbe 2012; 12:177–186 [View Article] [PubMed]
    [Google Scholar]
  51. Kogay R, Wolf YI, Koonin EV. Defence systems and horizontal gene transfer in bacteria. Environ Microbiol 2024; 26:e16630 [View Article] [PubMed]
    [Google Scholar]
  52. Levin BR. Nasty viruses, costly plasmids, population dynamics, and the conditions for establishing and maintaining CRISPR-mediated adaptive immunity in bacteria. PLoS Genet 2010; 6:e1001171 [View Article]
    [Google Scholar]
  53. Shen J, Adnan M, Khan AS, Fries BC et al. CRISPR-Cas influences the acquisition of antibiotic resistance in Klebsiella pneumoniae. PLoS One 2019; 14:e0225131 [View Article]
    [Google Scholar]
  54. Palmer KL, Gilmore MS. Multidrug-resistant enterococci lack CRISPR- cas.Losick R, editor. mBio 2010; 1:e00227-10 [View Article] [PubMed]
    [Google Scholar]
  55. Pursey E, Dimitriu T, Paganelli FL, Westra ER, van Houte S. CRISPR-Cas is associated with fewer antibiotic resistance genes in bacterial pathogens. Phil Trans R Soc B 2022; 377: [View Article]
    [Google Scholar]
  56. Wheatley RM, MacLean RC. CRISPR-Cas systems restrict horizontal gene transfer in Pseudomonas aeruginosa. ISME J 2021; 15:1420–1433 [View Article] [PubMed]
    [Google Scholar]
  57. Deveau H, Barrangou R, Garneau JE, Labonté J, Fremaux C et al. Phage response to CRISPR-encoded resistance in Streptococcus thermophilus. J Bacteriol 2008; 190:1390–1400 [View Article] [PubMed]
    [Google Scholar]
  58. Edraki A, Mir A, Ibraheim R, Gainetdinov I, Yoon Y et al. A compact, high-accuracy Cas9 with a dinucleotide PAM for in vivo genome editing. Mol Cell 2019; 73:714–726 [View Article] [PubMed]
    [Google Scholar]
  59. Paez-Espino D, Sharon I, Morovic W, Stahl B, Thomas BC et al. CRISPR immunity drives rapid phage genome evolution in Streptococcus thermophilus. mBio 2015; 6:1–9 [View Article] [PubMed]
    [Google Scholar]
  60. Catchpowle J, Maynard J, Chang BJ, Payne MS, Beeton ML et al. Miniscule Mollicutes: current hurdles to bacteriophage identification. Sustain Microbiol 2024; 1: [View Article]
    [Google Scholar]
  61. Dieppa-Colón E, Martin C, Anantharaman K. Prophage-DB: a comprehensive database to explore diversity, distribution, and ecology of prophages. bioRxiv 20242024.07.11.603044 [View Article] [PubMed]
    [Google Scholar]
  62. Day JM, Oakley BB, Seal BS, Zsak L. Comparative analysis of the intestinal bacterial and RNA viral communities from sentinel birds placed on selected broiler chicken farms. PLoS One 2015; 10:e0117210 [View Article] [PubMed]
    [Google Scholar]
  63. Patterson AG, Yevstigneyeva MS, Fineran PC. Regulation of CRISPR-Cas adaptive immune systems. Curr Opin Microbiol 2017; 37:1–7 [View Article] [PubMed]
    [Google Scholar]
  64. García-Martínez J, Maldonado RD, Guzmán NM, Mojica FJM. The CRISPR conundrum: evolve and maybe die, or survive and risk stagnation. Microb Cell 2018; 5:262–268 [View Article] [PubMed]
    [Google Scholar]
  65. Bonneaud C, Balenger SL, Russell AF, Zhang J, Hill GE et al. Rapid evolution of disease resistance is accompanied by functional changes in gene expression in a wild bird. Proc Natl Acad Sci U S A 2011; 108:7866–7871 [View Article] [PubMed]
    [Google Scholar]
  66. Bonneaud C, Weinert LA, Kuijper B. Understanding the emergence of bacterial pathogens in novel hosts. Phil Trans R Soc B 2019; 374:20180328 [View Article]
    [Google Scholar]
  67. Dowling AJ, Hill GE, Bonneaud C. Multiple differences in pathogen-host cell interactions following a bacterial host shift. Sci Rep 2020; 10:6779 [View Article] [PubMed]
    [Google Scholar]
  68. Nolan PM, Hill GE, Stoehr AM. Sex, size, and plumage redness predict house finch survival in an epidemic. Proc R Soc Lond B 1998; 265:961–965 [View Article]
    [Google Scholar]
  69. Adelman JS, Mayer C, Hawley DM. Infection reduces anti-predator behaviors in house finches. J Avian Biol 2017; 48:519–528 [View Article] [PubMed]
    [Google Scholar]
  70. Roberts SR, Nolan PM, Hill GE. Characterization of Mycoplasma gallisepticum Infection in captive house finches (Carpodacus mexicanus) in 1998. Avian Dis 2001; 45:70 [View Article]
    [Google Scholar]
  71. Bonneaud C, Tardy L, Hill GE, McGraw KJ, Wilson AJ et al. Experimental evidence for stabilizing selection on virulence in a bacterial pathogen. Evol Lett 2020; 4:491–501 [View Article] [PubMed]
    [Google Scholar]
/content/journal/mgen/10.1099/mgen.0.001320
Loading
/content/journal/mgen/10.1099/mgen.0.001320
Loading

Data & Media loading...

Supplements

Loading data from figshare Loading data from figshare
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error